Cognitive correlates in amyotrophic lateral sclerosis: A population-based study in Italy

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 86, Issue 2, 2015, Pages 168-173

  Montuschi, Anna ^a   Iazzolino, Barbara ^a   Calvo, Andrea ^a,b   Moglia, Cristina ^a   Lopiano, Leonardo ^b   Restagno, Gabriella ^b   Brunetti, Maura ^b   Ossola, Irene ^b   Lo Presti, Anna ^a   Cammarosano, Stefania ^a   Canosa, Antonio ^a   Chiò, Adriano ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b Azienda Ospedaliera Città della Salute e della Scienza   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; C9ORF72 PROTEIN, HUMAN; DNA BINDING PROTEIN; PROTEIN; PROTEIN TDP-43; SUPEROXIDE DISMUTASE;

AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APTITUDE TEST; ARTICLE; BEHAVIOR DISORDER; C9ORF72 GENE; COGNITION ASSESSMENT; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; EXECUTIVE COGNITIVE IMPAIRMENT; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE; GENE MUTATION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; NEUROPSYCHOLOGICAL TEST; NON CLASSIFIABLE COGNITIVE IMPAIRMENT; NON EXECUTIVE COGNITIVE IMPAIRMENT; OVERALL SURVIVAL; SOD1 GENE; SURVIVAL TIME; TARBDP GENE; CASE CONTROL STUDY; CLASSIFICATION; COGNITION DISORDERS; COMPLICATION; GENETICS; MUTATION; PSYCHOLOGY; RISK FACTOR; SURVIVAL;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; CASE-CONTROL STUDIES; COGNITION DISORDERS; DNA-BINDING PROTEINS; FEMALE; HUMANS; ITALY; MALE; MUTATION; NEUROPSYCHOLOGICAL TESTS; PROTEINS; RISK FACTORS; SUPEROXIDE DISMUTASE; SURVIVAL ANALYSIS;

EID: 84921403905     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2013-307223     Document Type: Article

References (32)

1. Chiò A, Calvo A, Mazzini L, et al. Extensive genetics of ALS: a population-based study in Italy. Neurology 2012;79:1983-9.
2. Kenna KP, McLaughlin RL, Byrne S, et al. Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing. J Med Genet 2013;50:776-83.
3. Lomen-Hoerth C, Murphy J, Langmore S, et al. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 2003;60:1094-7.
4. Phukan J, Elamin M, Bede P, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 2011;83:102-8.
5. Strong MJ, Grace GM, Freedman M, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioral syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2009;10:131-46.
6. Chiò A, Mora G, Calvo A, et al. Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology 2009;72:725-31.
7. Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-9.
8. Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999;169:13-21.
9. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-54.
10. Miceli G, Laudanna A, Burani C, et al. Batteria per l'Analisi dei Deficit Afasici B.A. D.A., Roma, CEPSAG, Università Cattolica del Sacro Cuore, 1994.
11. Warrington EK, James M. The Visual Object and Space Perception Battery (VOSP). Bury St. Edmunds, England: Thames Valley Test Co, 1991.
12. Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011;134:2456-77.
13. Grace J, Malloy P. Frontal Systems Behavior Scale (FrSBe): Professional Manual. Lutz, Fla, Psychological Assessment Resources, 2001.
14. Chiò A, Ilardi A, Cammarosano S, et al. Neurobehavioral dysfunction in ALS has a negative effect on outcome and use of PEG and NIV. Neurology 2012;78:1085-9.
15. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edn. text rev. American Psychiatric Press, Washington, DC, 2000.
16. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;3:939-44.
17. Renton AE, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-Linked ALS-FTD. Neuron 2011;72:257-68.
18. Banca d'Italia. Indagine sui Bilanci delle Famiglie Italiane. Anno 2010 http://www.bancaditalia.it/statistiche/indcamp/bilfait
19. Stern Y. Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol 2012;11:1006-12.
20. Kaplan RF, Cohen RA, Moscufo N, et al. Demographic and biological influences on cognitive reserve. J Clin Exp Neuropsychol 2009;31:868e76.
21. Borroni B, Premi E, Agosti C, et al. Revisiting brain reserve hypothesis in frontotemporal dementia: evidence from a brain perfusion study. Dement Geriatr Cogn Disord 2009;28:130-5.
22. Fairjones SE, Vuletich EJ, Pestell C, et al. Exploring the role of cognitive reserve in early-onset dementia. Am J Alzheimers Dis Other Demen 2011;26:139-44.
23. Gordon PH, Delgadillo D, Piquard A, et al. The range and clinical impact of cognitive impairment in French patients with ALS: a cross-sectional study of neuropsychological test performance. Amyotroph Lateral Scler 2011;12:372-8.
24. Rippon G, Scarmeas N, Gordon PH, et al. An observational study of cognitive impairment in amyotrophic lateral sclerosis. Arch Neurol 2006;63: 345-52.
25. Schreiber H, Gaigalat T, Wiedemuth-Catrinescu U, et al. Cognitive function in bulbar- and spinal-onset amyotrophic lateral sclerosis. A longitudinal study in 52 patients. J Neurol 2005;252:772-81.
26. Hu WT, Seelaar H, Josephs KA, et al. Survival profiles of patients with frontotemporal dementia and motor neuron disease. Arch Neurol 2009;66:1359-64.
27. Cistaro A, Valentini MC, Chiò A, et al. Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset. Eur J Nucl Med Mol Imaging 2012;39:251-9.
28. Byrne S, Elamin M, Bede P, et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol 2012;11:232-40.
29. Olney RK, Murphy J, Forshew D, et al. The effects of executive and behavioral dysfunction on the course of ALS. Neurology 2005;65:1774-7.
30. Elamin M, Phukan J, Bede P, et al. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology 2011;76:1263-9.
31. Elamin M, Bede P, Byrne S, et al. Cognitive changes predict functional decline in ALS: a population-based longitudinal study. Neurology 2013;80:1590-7.
32. Kilani M, Micallef J, Soubrouillard C, et al. A longitudinal study of the evolution of cognitive function and affective state in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2004;5:46-54.